ASI TECHNOLOGY CORPORATION APPOINTS GERALD L. EHRENS
TO BOARD OF DIRECTORS

(LAS VEGAS, Nevada, September 12, 2005)--ASI Technology Corporation (OTCBB: ASIT), an innovator of advanced plasma technologies, today announced the appointment of Gerald (Jerry) L. Ehrens as an independent director to its board of directors.

Mr. Ehrens has been a self-employed private investor since 1994. He brings over 20 years of corporate executive experience to the board of ASI. He previously served as Chief Operating Officer of Inamed Corp., a Nasdaq medical device company and had a major executive role in new business development at both Dupont and Union Carbide. In 1996, he was appointed as a director of unlisted publicly owned Commercial Bank of Nevada and served until its sale through merger to a NYSE bank group in 1998. He currently serves as a director of privately held SouthwestUSA Bank in Las Vegas, Nevada. He has a BS in Chemical Engineering from Princeton University and a MS in Industrial Administration from George Washington University.

"I am excited to add my business development experience to the board of ASI Technology," said Ehrens. "I have been following the company's plasma developments and believe the plasma sterilization and decontamination technology has tremendous potential for the rapid decontamination of medical equipment, military gear, food and packaging. I look forward to working with the other directors and the company's experienced plasma consultants on this important technology."

Jerry E. Polis, ASI President stated, "We are very pleased to have Jerry as a new member of the board. He brings considerable skills and experience to the company and his recent investment of $105,000 in the company illustrates a very strong commitment to our future."

About ASI Technology Corporation (www.asiplasma.com) - ASI specializes in the development of advanced plasma technologies. ASI has innovated new applications of plasma in the areas of antennas, communication links, electronic shielding, noise reduction and decontamination. The Company is currently focused on validating its cold plasma decontamination and sterilization method and developing prototypes. The Company also makes short-term investment loans for income to support operations.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This document contains forward-looking statements relating to future performance, technology and product development that may affect future results and the future viability of the company. Actual results could be affected or differ materially from those projected in the forward-looking statements as a result of risks and uncertainties, including development results, technological shifts, potential technical difficulties that could delay new technology, competition, general economic factors, the uncertainty of market acceptance of new technology, and other factors identified and discussed in the Company's most recent filings with the Securities and Exchange Commission. The Company's short-term investments are subject to many risks including default and nonpayment. Failure to collect on loans or investments could have an adverse effect on the Company's operations. These forward-looking statements are based on information and management's expectations as of the date hereof. Future results may differ materially from the Company's current expectations.

FOR FURTHER INFORMATION CONTACT:
Jerry E. Polis
President of ASI Technology
702.734.1888
jerrypolis@aol.com